Romesh Vaitilingam writes to draw my attention to the recent survey of economists, concerning Living-Donor Kidney Transplants, conducted by the Clark Center for Global Markets at Chicago Booth.
He says
" I’m writing now as I thought you might be interested in the results of this survey, which was inspired by reading your recent Wash Post column."*
Below are the three questions they asked, and the results to each one. At the survey link above you can find the responses of the individual economists surveyed.
Only one economist appeared to be skeptical about kidney exchange, and I was surprised at who it was (respondents may answer these questions very quickly...).
The next question concerns the End Kidney Deaths Act, which was introduced to the respondents at these links:
"There is draft legislation in Congress to increase the supply of human kidneys by encouraging donations to strangers: https://www.congress.gov/bill/119th-congress/house-bill/2687
"It is summarized here: https://www.hawaiibusiness.com/bipartisan-bill-aims-to-prevent-kidney-deaths-by-compensating-donors/ "
The End Kidney Deaths Act gets a good deal of support (above) while an unspecified decentralized market gets considerably less support, below.
###########
*Earlier posts
Friday, May 8, 2026 It’s time to carefully but urgently rethink payments to kidney donors. My op-ed in the Washington Post
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.